The potential value of the HOXB7/PBX2→miR-221&222→c-FOS pathway suggests the disruption of the HOXB7/PBX2 complexes, miR-221&222 inhibition or their combination as innovative therapeutic approaches in melanoma. This evidence concerns the gene FOS and melanoma.